← All news
Markets
RevMed’s Pancreatic Cancer Pill Priced Above $475K per Year
Revolution Medicines won US approval for a breakthrough pill that lengthens the lives of patients with advanced pancreatic cancer, a major advance against one of the hardest-to-treat tumor types. The once-daily drug carries a list price of…
Covered by 1 outlet
All coverage · 1 article